EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY-NC 4.0

Implementation of Site-Specific Hepatitis C Virus Treatment Workflows for Vulnerable, High-Risk Populations: A Prospective Single-Arm Trial

Anmol Desai iD, Kia Reinis, Lauren O'Neal, Patrick Chang, Cristal Brown iD, Michael Stefanowicz, Audrey Kuang, Deepak Agrawal, Tim Mercer iD, Darlene Bhavnani iD

Journal of Primary Care & Community Health · 2025

DOI: 10.1177/21501319251330622 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Journal of Primary Care & Community Health, 2025. Verfasst von Anmol Desai und 9 weiteren Autor:innen. Beteiligte Einrichtung: The University of Texas at Austin Dell Medical School, Austin, TX, USA. Hauptthemen laut MEDLINE: Antiviral Agents, Hepatitis C, Chronic, Vulnerable Populations, Workflow. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Gilead Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hepatitis C virus (HCV) treatment with pan-genotypic direct acting antivirals is highly effective, given an evidence-based simplified treatment algorithm. Yet access to treatment is limited among vulnerable populations.

Objective

We assessed the effectiveness of site-specific HCV treatment workflows on HCV care for vulnerable populations in Austin, Texas.

Methods

Patients diagnosed with chronic hepatitis C enrolled in care at a study site were eligible for this prospective, single-arm clinical trial. We assessed the proportion of participants that: (1) were prescribed treatment, (2) initiated treatment, (3) completed treatment, (4) were assessed for cure, and (5) achieved cure. We also evaluated implementation using the reach, effectiveness, adoption, implementation, and maintenance (RE-AIM) framework.

Results

Of 62 participants, 89% had ever experienced homelessness and 94% had ever used drugs. An estimated 66% (95% CrI, 42%-84%) were prescribed treatment and 49% (95% CrI, 26%-70%) initiated treatment. An estimated 38% (95% CrI, 20%-58%) completed treatment, 14% (95% CrI, 4%-44%) were assessed for cure, and 10% (95% CrI, 2%-35%) achieved cure.

Conclusions

We identified gaps along the HCV care cascade between: (1) enrolled to prescribed treatment and (2) completed treatment to assessed for cure. Site-specific HCV treatment workflows were insufficient to engage participants in care and avoid treatment delays. Novel approaches are needed and these may include patient outreach, patient navigation, test-and-treat protocols, and removing financial or payor barriers to medication access. Trial Registration: Registered on ClinicalTrials.gov on July, 14, 2022. Identifier: NCT05460130. https://clinicaltrials.gov/ct2/show/NCT05460130 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsHepatitis C, ChronicVulnerable PopulationsWorkflowAdultFemaleHumansMaleMiddle AgedHepacivirusIll-Housed PersonsProspective StudiesTexas

Stichwörter der Autor:innen

hepatitis Cimplementation researchpeople experiencing homelessness (PEH)people who inject drugs (PWID)primary care

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • The University of Texas at Austin Dell Medical School, Austin, TX, USA.
  • CommUnityCare, Austin, TX, USA.
  • Central Health, Austin, TX, USA.

ORCID-Profile: Anmol Desai, Cristal Brown, Tim Mercer, Darlene Bhavnani

Förderung

  • Gilead Sciences

Zitieren

APA

Desai, A., Reinis, K., O'Neal, L., Chang, P., Brown, C., Stefanowicz, M., Kuang, A., Agrawal, D., Mercer, T., & Bhavnani, D. (2025). Implementation of Site-Specific Hepatitis C Virus Treatment Workflows for Vulnerable, High-Risk Populations: A Prospective Single-Arm Trial. Journal of Primary Care & Community Health. https://doi.org/10.1177/21501319251330622

Vancouver

Desai A, Reinis K, O'Neal L, Chang P, Brown C, Stefanowicz M, et al. Implementation of Site-Specific Hepatitis C Virus Treatment Workflows for Vulnerable, High-Risk Populations: A Prospective Single-Arm Trial. Journal of Primary Care & Community Health. 2025. doi:10.1177/21501319251330622

BibTeX
@article{Desai2025,
  author = {Desai, Anmol and Reinis, Kia and O'Neal, Lauren and Chang, Patrick and Brown, Cristal and Stefanowicz, Michael and Kuang, Audrey and Agrawal, Deepak and Mercer, Tim and Bhavnani, Darlene},
  title = {Implementation of Site-Specific Hepatitis C Virus Treatment Workflows for Vulnerable, High-Risk Populations: A Prospective Single-Arm Trial},
  journal = {Journal of Primary Care & Community Health},
  year = {2025},
  doi = {10.1177/21501319251330622}
}
Kostenlos starten →